CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC - PubMed (original) (raw)
. 2012 Mar 23;419(4):612-6.
doi: 10.1016/j.bbrc.2012.02.050. Epub 2012 Feb 20.
Affiliations
- PMID: 22382030
- DOI: 10.1016/j.bbrc.2012.02.050
CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC
Ada Congrains et al. Biochem Biophys Res Commun. 2012.
Abstract
ANRIL is a newly discovered non-coding RNA lying on the strongest genetic susceptibility locus for cardiovascular disease (CVD) in the chromosome 9p21 region. Genome-wide association studies have been linking polymorphisms in this locus with CVD and several other major diseases such as diabetes and cancer. The role of this non-coding RNA in atherosclerosis progression is still poorly understood. In this study, we investigated the implication of ANRIL in the modulation of gene sets directly involved in atherosclerosis. We designed and tested siRNA sequences to selectively target two exons (exon 1 and exon 19) of the transcript and successfully knocked down expression of ANRIL in human aortic vascular smooth muscle cells (HuAoVSMC). We used a pathway-focused RT-PCR array to profile gene expression changes caused by ANRIL knock down. Notably, the genes affected by each of the siRNAs were different, suggesting that different splicing variants of ANRIL might have distinct roles in cell physiology. Our results suggest that ANRIL splicing variants play a role in coordinating tissue remodeling, by modulating the expression of genes involved in cell proliferation, apoptosis, extra-cellular matrix remodeling and inflammatory response to finally impact in the risk of cardiovascular disease and other pathologies.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
- Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis.
Chi JS, Li JZ, Jia JJ, Zhang T, Liu XM, Yi L. Chi JS, et al. J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):816-822. doi: 10.1007/s11596-017-1812-y. Epub 2017 Dec 21. J Huazhong Univ Sci Technolog Med Sci. 2017. PMID: 29270737 Review. - Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.
Congrains A, Kamide K, Oguro R, Yasuda O, Miyata K, Yamamoto E, Kawai T, Kusunoki H, Yamamoto H, Takeya Y, Yamamoto K, Onishi M, Sugimoto K, Katsuya T, Awata N, Ikebe K, Gondo Y, Oike Y, Ohishi M, Rakugi H. Congrains A, et al. Atherosclerosis. 2012 Feb;220(2):449-55. doi: 10.1016/j.atherosclerosis.2011.11.017. Epub 2011 Nov 19. Atherosclerosis. 2012. PMID: 22178423 - Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.
Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z, Sharpless NE. Burd CE, et al. PLoS Genet. 2010 Dec 2;6(12):e1001233. doi: 10.1371/journal.pgen.1001233. PLoS Genet. 2010. PMID: 21151960 Free PMC article. - Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
Pasmant E, Sabbagh A, Masliah-Planchon J, Ortonne N, Laurendeau I, Melin L, Ferkal S, Hernandez L, Leroy K, Valeyrie-Allanore L, Parfait B, Vidaud D, Bièche I, Lantieri L, Wolkenstein P, Vidaud M; NF France Network. Pasmant E, et al. J Natl Cancer Inst. 2011 Nov 16;103(22):1713-22. doi: 10.1093/jnci/djr416. Epub 2011 Oct 27. J Natl Cancer Inst. 2011. PMID: 22034633 - ANRIL and atherosclerosis.
Chen L, Qu H, Guo M, Zhang Y, Cui Y, Yang Q, Bai R, Shi D. Chen L, et al. J Clin Pharm Ther. 2020 Apr;45(2):240-248. doi: 10.1111/jcpt.13060. Epub 2019 Nov 8. J Clin Pharm Ther. 2020. PMID: 31703157 Review.
Cited by
- lncRNome: a comprehensive knowledgebase of human long noncoding RNAs.
Bhartiya D, Pal K, Ghosh S, Kapoor S, Jalali S, Panwar B, Jain S, Sati S, Sengupta S, Sachidanandan C, Raghava GP, Sivasubbu S, Scaria V. Bhartiya D, et al. Database (Oxford). 2013 Jul 11;2013:bat034. doi: 10.1093/database/bat034. Print 2013. Database (Oxford). 2013. PMID: 23846593 Free PMC article. - New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease.
Yuan W, Zhang W, Zhang W, Ruan ZB, Zhu L, Liu Y, Mi YY, Zhang LF. Yuan W, et al. Bioengineered. 2020 Dec;11(1):1084-1098. doi: 10.1080/21655979.2020.1827892. Bioengineered. 2020. PMID: 33054494 Free PMC article. - Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus.
Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li YJ, Yan B, Jiang Q. Liu JY, et al. Cell Death Dis. 2014 Oct 30;5(10):e1506. doi: 10.1038/cddis.2014.466. Cell Death Dis. 2014. PMID: 25356875 Free PMC article. - Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis.
Chi JS, Li JZ, Jia JJ, Zhang T, Liu XM, Yi L. Chi JS, et al. J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):816-822. doi: 10.1007/s11596-017-1812-y. Epub 2017 Dec 21. J Huazhong Univ Sci Technolog Med Sci. 2017. PMID: 29270737 Review. - The Role of Long Non-coding RNAs in Sepsis-Induced Cardiac Dysfunction.
Li J, Zhang Y, Zhang D, Li Y. Li J, et al. Front Cardiovasc Med. 2021 May 10;8:684348. doi: 10.3389/fcvm.2021.684348. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34041287 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical